After $400M exit, Medigate’s founders launch new cybersecurity startup
The stealth venture, currently named ACT, has raised $20 million in Seed funding from Team8 and Bessemer to tackle cloud risks.
The founders of Medigate, which was acquired by Claroty for about $400 million in 2021, are launching a new cybersecurity company, Calcalist has learned.
Full list of Israeli high-tech funding rounds in 2025
Jonathan Langer and Itay Kirshenbaum have left Claroty to join Stephen Goldberg, a former senior executive at Claroty, and Ilai Fallach, an experienced executive in several cybersecurity companies, to establish a new venture that is still operating in stealth.
The company, currently called ACT, has so far raised $20 million in a Seed round from investors including Team8 and U.S. venture capital firm Bessemer Venture Partners.
ACT will be led by Langer, formerly COO of Claroty; Goldberg, who will serve as Chief Product Officer; Kirshenbaum, the new company’s Chief Technology Officer; and Fallach. ACT aims to provide a layer of protection beyond visibility and vulnerability disclosure, enabling security teams to take concrete, effective action to reduce risk in cloud environments.
Related articles:
Medigate, founded in 2017 by Langer, Kirshenbaum and Pini Pinhasov, had raised only $50 million before its acquisition. The company developed a dedicated cybersecurity platform for medical devices, the Internet of Medical Things (IoMT), used in hospitals and healthcare institutions. Its technology addressed a specific challenge: medical devices such as monitors, CT scanners, and infusion pumps are often connected to hospital networks but are not adequately protected by generic security solutions.
Claroty operates in the field of cybersecurity for essential facilities and critical infrastructure. Last year, there was market speculation that the company was considering an IPO at a valuation of $3.5 billion, with annual revenues estimated at about $400 million.
